TABLE OF CONTENTS

1              Introduction

1.1          Market Definition

1.2          Market Scope

2              Research Methodology

2.1          Primary Research

2.2          Research Methodology

2.3          Assumptions & Exclusions

2.4          Secondary Data Sources

3              Market Overview

3.1          Report Segmentation & Scope

3.2          Value Chain Analysis: Occlusion Devices Market

3.3          Key Market Trends

3.3.1      Drivers

3.3.2      Restraints

3.3.3      Opportunities

3.4          Porter’s Five Forces Analysis

3.4.1      Bargaining Power of Suppliers

3.4.2      Bargaining Power of Buyers

3.4.3      Threat of Substitution

3.4.4      Threat of New Entrants

3.4.5      Competitive Rivalry

3.5          Market Share Analysis

4              By Product

4.1          Introduction

4.1.1      Market Size & Forecast (Value)

4.2          Occlusion Removal Devices

              4.3          Embolization Devices

             4.4       Support Devices

5              By Application

5.1          Introduction

5.1.1              Market Size & Forecast (Value)

5.2         Neurology

5.3          Cardiology

5.4          Peripheral Vascular Diseases

5.5          Urology

5.6          Oncology

5.7       Gynecology

6              Regional Overview

6.1          Introduction

6.1.1      Market Size & Forecast (Value)

6.2          America

6.2.1      North America

6.2.1.1   U.S.

6.2.1.1.1               By Product

6.2.1.1.2              By Application  

6.2.1.2   Canada

6.2.1.2.1               By Product

6.2.1.2.2               By Application  

6.2.1.3   Mexico

6.2.1.3.1               By Product

6.2.1.1.2              By Application  

6.2.2      Latin America

6.2.2.1                   By Product

6.2.2.2                  By Application  

6.3          Europe

6.3.1      Market Size & Forecast (Value)

6.3.2      Germany

6.3.2.1                   By Product

6.3.2.2                   By Application  

6.3.3      France

6.3.3.1                   By Product

6.3.3.2                   By Application  

6.3.4      U.K.

6.3.4.1                   By Product

6.3.4.2                   By Application  

6.3.5      Italy

6.3.5.1                   By Product

6.3.5.2                   By Application  

6.3.6      Spain

6.3.6.1                   By Product

6.3.6.2                   By Application  

6.3.7      Rest of Europe

6.3.7.1                   By Product

6.3.7.2                  By Application  

6.4          Asia Pacific

6.4.1      Market Size & Forecast (Value)

6.4.2      Japan

6.4.2.1                   By Product

6.4.2.2                   By Application  

6.4.3      China

6.4.3.1                   By Product

6.4.3.2                  By Application  

6.4.4      Australia

6.4.4.1                   By Product

6.4.4.2                   By Application  

6.4.5      India

6.4.5.1                   By Product

6.4.5.2                   By Application  

6.4.6      South Korea

6.4.6.1                   By Product

6.4.6.2                   By Application  

6.4.7      Rest of Asia-Pacific

6.4.7.1                   By Product

6.4.7.2                   By Application  

6.5          Middle East & Africa

6.5.1      Market Size & Forecast (Value)

6.5.2      Saudi Arabia

6.5.2.1                   By Product

6.5.2.2                   By Application  

6.5.3      South Africa

6.5.3.1                   By Product

6.5.3.2                   By Application  

6.5.4      Kuwait

6.5.4.1                   By Product

6.5.4.2                   By Application  

6.5.5      Rest of Middle East & Africa

6.5.5.1                   By Product

6.5.5.2                   By Application  

7.            Company Profile

7.1          Acrostak

7.1.1      Company Overview

7.1.2      Financial Performance

7.1.3      Recent Developments

7.1.4      Product Portfolio

7.2          Abbott Laboratories

7.2.1      Company Overview

7.2.2      Financial Performance

7.2.3      Recent Developments

7.2.4      Product Portfolio

7.3          Asahi Intecc

7.3.1      Company Overview

7.3.2      Financial Performance

7.3.3      Recent Developments

7.3.4      Product Portfolio

7.4          Angiodynamics

7.4.1      Company Overview

7.4.2      Financial Performance

7.4.3      Recent Developments

7.4.4      Product Portfolio

7.5          Cardinal Health

7.5.1      Company Overview

7.5.2      Financial Performance

7.5.3      Recent Developments

7.5.4      Product Portfolio

7.6          Avinger

7.6.1      Company Overview

7.6.2      Financial Performance

7.6.3      Recent Developments

7.6.4      Product Portfolio

7.7          Edwards Lifesciences

7.7.1      Company Overview

7.7.2      Financial Performance

7.7.3      Recent Developments

7.7.4      Product Portfolio

7.8          Cook Group

7.8.1      Company Overview

7.8.2      Financial Performance

7.8.3      Recent Developments

7.8.4      Product Portfolio

7.9          Stryker Corporation

7.9.1      Company Overview

7.9.2      Financial Performance

7.9.3      Recent Developments

7.9.4      Product Portfolio

7.10        Penumbra

7.10.1    Company Overview

7.10.2    Financial Performance

7.10.3    Recent Developments

7.10.4    Product Portfolio

7.11        B. Braun Melsungen AG

7.11.1    Company Overview

7.11.2    Financial Performance

7.11.3    Recent Developments

7.11.4    Product Portfolio

7.12        Terumo Corporation

7.12.1    Company Overview

7.12.2    Financial Performance

7.12.3    Recent Developments

7.12.4    Product Portfolio